1-7 of 7
Ann G. Zauber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma

Andrew T. Chan, Meier Hsu, Ann G. Zauber, Ernest T. Hawk, Monica M. Bertagnolli
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (1): 61–72.
DOI: https://doi.org/10.1158/1940-6207.CAPR-11-0337
Published: 03 January 2012
View article
PDF
Includes: Supplementary data
Journal Articles

C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment

Andrew T. Chan, Camelia S. Sima, Ann G. Zauber, Paul M. Ridker, Ernest T. Hawk, Monica M. Bertagnolli
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (8): 1172–1180.
DOI: https://doi.org/10.1158/1940-6207.CAPR-10-0403
Published: 03 August 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Statin Use and Colorectal Adenoma Risk: Results from the Adenoma Prevention with Celecoxib Trial

Monica M. Bertagnolli, Meier Hsu, Ernest T. Hawk, Craig J. Eagle, Ann G. Zauber
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (5): 588–596.
DOI: https://doi.org/10.1158/1940-6207.CAPR-09-0271
Published: 04 May 2010
View article
PDF
Includes: Supplementary data
Journal Articles

Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial

Monica M. Bertagnolli, Craig J. Eagle, Ann G. Zauber, Mark Redston, Aurora Breazna, KyungMann Kim, Jie Tang, Rebecca B. Rosenstein, Asad Umar, Donya Bagheri, Neal T. Collins, John Burn, Daniel C. Chung, Thomas Dewar, T. Raymond Foley, Neville Hoffman, Finlay Macrae, Ronald E. Pruitt, John R. Saltzman, Bruce Salzberg, Thomas Sylwestrowicz, Ernest T. Hawk, for the Adenoma Prevention with Celecoxib Study Investigators
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (4): 310–321.
DOI: https://doi.org/10.1158/1940-6207.CAPR-08-0206
Published: 06 April 2009
View article
PDF
Includes: Supplementary data
Journal Articles

Prostaglandin Inhibition and Cardiovascular Risk: Maybe Timing Really Is Everything

Monica M. Bertagnolli, Ann G. Zauber, Scott Solomon
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (3): 195–196.
DOI: https://doi.org/10.1158/1940-6207.CAPR-08-0245
Published: 05 March 2009
View article
PDF
Includes: Supplementary data
Journal Articles

Comment re: “Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention” and “Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial”

Ann G. Zauber, Monica M. Bertagnolli, for the APC Trial Investigators
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (3): 216.
DOI: https://doi.org/10.1158/1940-6207.CAPR-08-0131
Published: 25 July 2008
View article
PDF
Journal Articles

Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial

Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, Monica M. Bertagnolli
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (1): 21–31.
DOI: https://doi.org/10.1158/1940-6207.CAPR-07-0011
Published: 09 June 2008
View article
PDF
Includes: Supplementary data